Lippincott Williams & Wilkins (LWW), a division of Wolters Kluwer Health, has signed an agreement with the American Association of Neuroscience Nurses’s official journal.
Everyday Health climbs past WebMD
November 15, 2008
10:20 pm
In the battle for unique visitors, Waterfront Media’s Everyday Health has surpassed WebMD to lead the online consumer health space.
Mirapex promotional violations cited
November 15, 2008
10:18 pm
Two consumer-directed pharmacy printouts and a professionally directed labeling piece for Boehringer-Ingelheim’s Mirapex were considered misleading, according to a warning letter from FDA’s DDMAC.
FDA’s Troy ‘was a pre-emption guru’
November 15, 2008
10:17 pm
The American Association for Justice said federal agency documents it obtained through Freedom of Information Act requests show that former FDA chief counsel Daniel Troy was responsible for the Bush administration’s efforts to pre-empt state liability claims in many federal agencies.
Public Citizen seeks Ortho Evra ban
November 15, 2008
10:16 pm
Ortho-McNeil/Janssen said a Public Citizen petition to the FDA calling for removal of the Ortho Evra contraceptive patch from the market for safety reasons “presents no new information or scientific evidence showing that Ortho Evra is unsafe, ineffective or unnecessary” and should be denied.
Rx safety hasn’t made agency ‘conservative’
November 15, 2008
10:11 pm
The FDA’s director of drug evaluation and research, Janet Woodcock, denied in October that an increased focus on drug safety in recent years, fueled by public and congressional criticism of the agency’s safety oversight, has made her Center more “conservative.”
Watch those advertising and promo claims, say laywers
Attorneys at the Washington law firm of McDermott Will & Emery advised in October that companies wishing to avoid FDA challenges to drug ads and promotional pieces should review their materials in all therapeutic categories to determine whether they make implied outcomes claims.
The traditional sales force model is no longer effective as doctors are no longer the key prescribing decision makers, according to the results of a report conducted by Research and Markets.